References
- Agnès, F., & Perron, M. (2004). RNA-binding proteins and neural development: a matter of targets and complexes. Neuroreport, 15(17), 2567–2570. doi:https://doi.org/10.1097/00001756-200412030-00001
- Angarica, V.E., & Del Sol, A. (2017). Bioinformatics tools for genome-wide epigenetic research. Advances in Experimental Medicine and Biology, 978, 489–512. doi:https://doi.org/10.1007/978-3-319-53889-1_25
- Baranello, R.J., Bharani, K.L., Padmaraju, V., Chopra, N., Lahiri, D.K., Greig, N.H., … Sambamurti, K. (2015). Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease. Current Alzheimer Research, 12(1), 32–46. doi:https://doi.org/10.2174/1567205012666141218140953
- Barros de Andrade E Sousa, L., Jonkers, I., Syx, L., Dunkel, I., Chaumeil, J., Picard, C., … Marsico, A. (2019). Kinetics of Xist-induced gene silencing can be predicted from combinations of epigenetic and genomic features. Genome Research, 29(7), 1087–1099. doi:https://doi.org/10.1101/gr.245027.118
- Breijyeh, Z., & Karaman, R. (2020). Comprehensive review on Alzheimer's disease: Causes and treatment. Molecules, 25(24), 5789. doi:https://doi.org/10.3390/molecules25245789
- Cenini, G., Hebisch, M., Iefremova, V., Flitsch, L.J., Breitkreuz, Y., Tanzi, R.E., … Brüstle, O. (2021). Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models. Molecular and Cellular Neurosciences, 110, 103568. doi:https://doi.org/10.1016/j.mcn.2020.103568
- Chacon-De-La-Rocha, I., Fryatt, G., Rivera, A.D., Verkhratsky, A., Raineteau, O., Gomez-Nicola, D., & Butt, A.M. (2020). Accelerated dystrophy and decay of oligodendrocyte precursor cells in the APP/PS1 model of Alzheimer's-like pathology. Front Cell Neuroscience, 14, 575082. doi:https://doi.org/10.3389/fncel.2020.575082
- Chanda, K., & Mukhopadhyay, D. (2020). LncRNA Xist, X-chromosome instability and Alzheimer's disease. Current Alzheimer Research, 17(6), 499–507. doi:https://doi.org/10.2174/1567205017666200807185624
- Chonpathompikunlert, P., Han, J., Toh, K., Isoda, H., & Nagasaki, Y. (2011). TEMPOL protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell toxicity. European Journal of Pharmacology, 650(2–3), 544–549. doi:https://doi.org/10.1016/j.ejphar.2010.10.028
- Cummings, J.L., Tong, G., & Ballard, C. (2019). Treatment combinations for Alzheimer's disease: Current and future pharmacotherapy options. Journal of Alzheimer's Disease, 67(3), 779–794. doi:https://doi.org/10.3233/jad-180766
- Elcheva, I.A., & Spiegelman, V.S. (2021). Targeting RNA-binding proteins in acute and chronic leukemia. Leukemia, 35(2), 360–376. doi:https://doi.org/10.1038/s41375-020-01066-4
- Ferrè, F., Colantoni, A., & Helmer-Citterich, M. (2016). Revealing protein-lncRNA interaction. Briefings in Bioinformatics, 17(1), 106–116. doi:https://doi.org/10.1093/bib/bbv031
- Fotuhi, S.N., Khalaj-Kondori, M., Hoseinpour Feizi, M.A., & Talebi, M. (2019). Long non-coding RNA BACE1-AS may serve as an Alzheimer's disease blood-based biomarker. Journal of Molecular Neuroscience : MN, 69(3), 351–359. doi:https://doi.org/10.1007/s12031-019-01364-2
- Grimm, M.O., Mett, J., Stahlmann, C.P., Haupenthal, V.J., Zimmer, V.C., & Hartmann, T. (2013). Neprilysin and Aβ clearance: Impact of the APP intracellular domain in NEP regulation and implications in Alzheimer's disease. Frontiers in Aging Neuroscience, 5, 98. doi:https://doi.org/10.3389/fnagi.2013.00098
- Høgh, P. (2017). Alzheimer's disease. Ugeskr Laeger, 179(12), 505–508.
- Ke, S., Yang, Z., Yang, F., Wang, X., Tan, J., & Liao, B. (2019). Long noncoding RNA NEAT1 aggravates Aβ-induced neuronal damage by targeting miR-107 in Alzheimer's disease. Yonsei Medical Journal, 60(7), 640–650. doi:https://doi.org/10.3349/ymj.2019.60.7.640
- Kong, S., Tao, M., Shen, X., & Ju, S. (2020). Translatable circRNAs and lncRNAs: Driving mechanisms and functions of their translation products. Cancer Letters, 483, 59–65. doi:https://doi.org/10.1016/j.canlet.2020.04.006
- Krittanawong, C., & Kitai, T. (2017). Pharmacogenomics of angiotensin receptor/neprilysin inhibitor and its long-term side effects. Cardiovascular Therapeutics, 35(4), e12272. doi:https://doi.org/10.1111/1755-5922.12272
- Lane, C.A., Hardy, J., & Schott, J.M. (2018). Alzheimer's disease. European Journal of Neurology, 25(1), 59–70. doi:https://doi.org/10.1111/ene.13439/
- Liu, Y., Fang, S., Liu, L.M., Zhu, Y., Li, C.R., Chen, K., & Zhao, H.B. (2020). Hearing loss is an early biomarker in APP/PS1 Alzheimer's disease mice. Neuroscience Letters, 717, 134705. doi:https://doi.org/10.1016/j.neulet.2019.134705
- Ma, P., Li, Y., Zhang, W., Fang, F., Sun, J., Liu, M., … Dong, L. (2019). Long non-coding RNA MALAT1 inhibits neuron apoptosis and neuroinflammation while stimulates neurite outgrowth and its correlation with MiR-125b mediates PTGS2, CDK5 and FOXQ1 in Alzheimer's disease. Current Alzheimer Research, 16(7), 596–612. doi:https://doi.org/10.2174/1567205016666190725130134
- Miranda Furtado, C.L., Dos Santos Luciano, M.C., Silva Santos, R.D., Furtado, G.P., Moraes, M.O., & Pessoa, C. (2019). Epidrugs: Targeting epigenetic marks in cancer treatment. Epigenetics, 14(12), 1164–1176. doi:https://doi.org/10.1080/15592294.2019.1640546
- Nalivaeva, N.N., Zhuravin, I.A., & Turner, A.J. (2020). Neprilysin expression and functions in development, ageing and disease. Mechanisms of Ageing and Development, 192, 111363. doi:https://doi.org/10.1016/j.mad.2020.111363
- Omar, S.H., Scott, C.J., Hamlin, A.S., & Obied, H.K. (2018). Olive biophenols reduces Alzheimer's pathology in SH-SY5Y Cells and APPswe mice. International Journal of Molecular Sciences, 20(1), 125. doi:https://doi.org/10.3390/ijms20010125
- Qian, X., Zhao, J., Yeung, P.Y., Zhang, Q.C., & Kwok, C.K. (2019). Revealing lncRNA structures and interactions by sequencing-based approaches. Trends in Biochemical Sciences, 44(1), 33–52. doi:https://doi.org/10.1016/j.tibs.2018.09.012
- Qu, X., Li, Y., Wang, L., Yuan, N., Ma, M., & Chen, Y. (2020). LncRNA SNHG8 accelerates proliferation and inhibits apoptosis in HPV-induced cervical cancer through recruiting EZH2 to epigenetically silence RECK expression. Journal of Cellular Biochemistry, 121(10), 4120–4129. doi:https://doi.org/10.1002/jcb.29646
- Reiserer, R.S., Harrison, F.E., Syverud, D.C., & McDonald, M.P. (2007). Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes, Brain, and Behavior, 6(1), 54–65. doi:https://doi.org/10.1111/j.1601-183X.2006.00221.x
- Riva, P., Ratti, A., & Venturin, M. (2016). The long non-coding RNAs in neurodegenerative diseases: Novel mechanisms of pathogenesis. Current Alzheimer Research, 13(11), 1219–1231. doi:https://doi.org/10.2174/1567205013666160622112234
- Rivera-Escalera, F., Matousek, S.B., Ghosh, S., Olschowka, J.A., & O'Banion, M.K. (2014). Interleukin-1β mediated amyloid plaque clearance is independent of CCR2 signaling in the APP/PS1 mouse model of Alzheimer's disease. Neurobiology of Disease, 69, 124–133. doi:https://doi.org/10.1016/j.nbd.2014.05.018
- Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C.E., … van der Flier, W.M. (2021). Alzheimer's disease. Lancet, 397(10284), 1577–1590. doi:https://doi.org/10.1016/s0140-6736(20)32205-4
- Sorensen, K.C., Simonsen, A.H., Holmetoft, U.B., Hasselbalch, S.G., & Heegaard, N.H. (2013). Neprilysin-like activity correlates with CSF-Tau and phospho-tau in patients with Alzheimer's disease. Journal of Alzheimer's Disease, 37(2), 379–387. doi:https://doi.org/10.3233/jad-122410
- Soria Lopez, J.A., González, H.M., & Léger, G.C. (2019). Alzheimer's disease. Handbook of Clinical Neurology, 167, 231–255. doi:https://doi.org/10.1016/b978-0-12-804766-8.00013-3
- Turner, A.J., Isaac, R.E., & Coates, D. (2001). The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function. BioEssays, 23(3), 261–269. doi:https://doi.org/10.1002/1521-1878(200103)23:3 < 261::Aid-bies1036 > 3.0.Co;2-k
- Wang, S.-H., Ma, F., Tang, Z.-H., Wu, X.-C., Cai, Q., Zhang, M.-D., … Quan, Z.-W. (2016). Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer. Journal of Experimental & Clinical Cancer Research, 35(1), 160. doi:https://doi.org/10.1186/s13046-016-0436-6
- Wang, S., Zhang, Y., Cai, Q., Ma, M., Jin, L.Y., Weng, M., … Quan, Z. (2019). Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression. Molecular Cancer, 18(1), 145. doi:https://doi.org/10.1186/s12943-019-1078-z
- Wang, X., Wang, C., Geng, C., & Zhao, K. (2018). LncRNA XIST knockdown attenuates Aβ(25-35)-induced toxicity, oxidative stress, and apoptosis in primary cultured rat hippocampal neurons by targeting miR-132. International Journal of Clinical Experimental Pathology, 11(8), 3915–3924.
- Weller, J., & Budson, A. (2018). Current understanding of Alzheimer's disease diagnosis and treatment. F1000Research, 7, 1161. doi:https://doi.org/10.12688/f1000research.14506.1
- Yue, D., Guanqun, G., Jingxin, L., Sen, S., Shuang, L., Yan, S., … Yafen, W. (2020). Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124. Cell Biol Int, 44(2), 630–636. doi:https://doi.org/10.1002/cbin.11263
- Zang, X., Gu, J., Zhang, J., Shi, H., Hou, S., Xu, X., … Zhang, X. (2020). Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression. Cell Death & Disease, 11(4), 215. doi:https://doi.org/10.1038/s41419-020-2409-0
- Zhang, J., & Wang, R. (2021). Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p. Experimental Gerontology, 144, 111180. doi:https://doi.org/10.1016/j.exger.2020.111180
- Zhang, Y.Y., Bao, H.L., Dong, L.X., Liu, Y., Zhang, G.W., & An, F.M. (2021). Silenced lncRNA H19 and up-regulated microRNA-129 accelerates viability and restrains apoptosis of PC12 cells induced by Aβ25-35 in a cellular model of Alzheimer's disease. Cell Cycle (Georgetown, Tex.), 20(1), 112–125. doi:https://doi.org/10.1080/15384101.2020.1863681
- Zhang, Y., Zhang, H., Zhang, W., Zhang, Y., Wang, W., & Nie, L. (2020). LncRNA XIST modulates 5-hydroxytrytophan-induced visceral hypersensitivity by epigenetic silencing of the SERT gene in mice with diarrhea-predominant IBS. Cell Signalling, 73, 109674. doi:https://doi.org/10.1016/j.cellsig.2020.109674/
- Zhou, H., Mangelsdorf, M., Liu, J., Zhu, L., & Wu, J.Y. (2014). RNA-binding proteins in neurological diseases. Science China Life Sciences, 57(4), 432–444. doi:https://doi.org/10.1007/s11427-014-4647-9